{"id":"https://genegraph.clinicalgenome.org/r/97d18f61-f97c-4733-a5cf-250fb34d0842v1.0","type":"EvidenceStrengthAssertion","dc:description":"**CASZ1** was first reported in relation to autosomal dominant congenital heart disease in 2016 (Huang et al., PMID: 27693370). 2 variants (missense) that have been reported in 5 probands in 2 publications (PMIDs: 27693370, 28641477) are included in this curation. The mechanism of pathogenicity appears to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (mouse model, expression-level evidence) (PMID: 25190801, NCBI Fetal Expression Data). Homozygous mutant mice show structural congenital heart anomalies. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 8/12/2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/97d18f61-f97c-4733-a5cf-250fb34d0842","GCISnapshot":"https://genegraph.clinicalgenome.org/r/754d56b3-0749-4292-b6c8-96ab61232076","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/754d56b3-0749-4292-b6c8-96ab61232076_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2024-08-12T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/754d56b3-0749-4292-b6c8-96ab61232076_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10130","date":"2024-08-21T12:33:00.752Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/754d56b3-0749-4292-b6c8-96ab61232076_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c465b39b-1c1c-4e85-81ae-11d17187c413","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c465b39b-1c1c-4e85-81ae-11d17187c413_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28641477","allele":{"id":"https://genegraph.clinicalgenome.org/r/cd677e1f-4434-4eed-a7f2-7b889aedac30","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079843.3(CASZ1):c.2242T>C (p.Ser748Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338365046"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/225df851-9eb2-4471-9a44-abc82ce6de47","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/225df851-9eb2-4471-9a44-abc82ce6de47_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Fold activation of the TH promoter-driven luciferase in HEK293 cells was substantially lower in the mutant than the CASZ1 wild-type; activation was partially recovered with wildtype CASZ1 expressed along with the mutant.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/225df851-9eb2-4471-9a44-abc82ce6de47_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27693370","allele":{"id":"https://genegraph.clinicalgenome.org/r/aa3bbe35-b383-4cf2-8ee5-b709fafc4933","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001079843.3(CASZ1):c.113T>C (p.Leu38Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338384049"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/754d56b3-0749-4292-b6c8-96ab61232076_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73196c31-e0e8-4b69-bd75-967948a00401_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27693370","rdfs:label":"p.Leu38Pro","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/73196c31-e0e8-4b69-bd75-967948a00401","type":"Family","rdfs:label":"p.Leu38Pro","member":{"id":"https://genegraph.clinicalgenome.org/r/f447efae-5d2e-4313-90d7-52053dbb80af","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27693370","rdfs:label":"p.Leu38Pro","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/aa3bbe35-b383-4cf2-8ee5-b709fafc4933"},"detectionMethod":"coding exons and flanking introns of CASZ1 analyzed","firstTestingMethod":"Genotyping","phenotypes":["obo:HP_0001629","obo:HP_0001719"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/225df851-9eb2-4471-9a44-abc82ce6de47_variant_evidence_item"}}},"phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0001629","proband":{"id":"https://genegraph.clinicalgenome.org/r/f447efae-5d2e-4313-90d7-52053dbb80af"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/754d56b3-0749-4292-b6c8-96ab61232076_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/754d56b3-0749-4292-b6c8-96ab61232076_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/052e9bd6-6648-4586-b62a-cbbc3f54c7f5","type":"EvidenceLine","dc:description":"Homozygous mutants had anomalies, but heterozygotes did not. Affected humans have heterozygous mutations. Also, the phenotype is not super specific with affected individuals having both structural congenital heart disease and cardiomyopathy. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44c2824b-140c-47f4-b9ef-a602b528330d","type":"Finding","dc:description":"The atypical heart morphology seen in mice is also found in affected humans. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25190801","rdfs:label":"Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/754d56b3-0749-4292-b6c8-96ab61232076_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/451432b2-8165-4fa9-86e3-760a02182fbd","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fad926b6-a4d8-40aa-9e59-7ab0e922f464","type":"Finding","dc:description":"There is very high expression of CASZ1 in the heart between 11 and 18 weeks gestation.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25190801","rdfs:label":"Fetal Expression Data from NCBI (NOT from this PMID)","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5}],"evidenceStrength":"Limited","sequence":8847,"specifiedBy":"GeneValidityCriteria10","strengthScore":2.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/atJKPVr881g","type":"GeneValidityProposition","disease":"obo:MONDO_0005453","gene":"hgnc:26002","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_754d56b3-0749-4292-b6c8-96ab61232076-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}